How do you pay?

How to pay the least

Ask for the cash price

HAEGARDA C1 Esterase Inhibitor Subcutaneous

This medicine is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

What to do

  1. Ask your pharmacy for HAEGARDA C1 Esterase Inhibitor Subcutaneous’s cash price, and one or two other pharmacies too.

Compare every option

Brand name

HAEGARDA C1 Esterase Inhibitor Subcutaneous, the original

Cash priceFree trialFrom the maker
Ways to save on the brand

The maker’s free trial

HAEGARDA QuickStart Program

Free trial from CSL Behring

HAEGARDA C1 Esterase Inhibitor Subcutaneous’s maker offers new patients a free trial. See its page for how to get it.

Sign up on haegarda.com 

Or call 1-844-423-4273.

From the maker’s site, checked November 17, 2026. Check the maker’s page for who can use it.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

This medicine is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldAsk the pharmacy

What it’s used for

What the FDA label says

HAEGARDA is a plasma-derived concentrate of C1 Esterase Inhibitor (Human) (C1-INH) indicated for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older.

Source: the FDA label for HAEGARDA C1 Esterase Inhibitor Subcutaneous (CSL Behring GmbH), February 4, 2022. Full label on DailyMed 

Good to know

  • “Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Check the maker’s page for who can use it.
  • Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.